Remon, J., & Majem, M. (2013). EGFR mutation heterogeneity and mixed response to EGFR tyrosine kinase inhibitors of non small cell lung cancer: A clue to overcoming resistance. Transl Lung Cancer Res.
Chicago Stili AlıntıRemon, Jordi, ve Margarita Majem. "EGFR Mutation Heterogeneity and Mixed Response to EGFR Tyrosine Kinase Inhibitors of Non Small Cell Lung Cancer: A Clue to Overcoming Resistance." Transl Lung Cancer Res 2013.
MLA AlıntıRemon, Jordi, ve Margarita Majem. "EGFR Mutation Heterogeneity and Mixed Response to EGFR Tyrosine Kinase Inhibitors of Non Small Cell Lung Cancer: A Clue to Overcoming Resistance." Transl Lung Cancer Res 2013.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..